Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule dynamics disruption refers to interference with the normal polymerization and depolymerization of microtubules—cytoskeletal filaments essential for cell division, intracellular transport, and maintenance of cell shape. This process is the pharmacological target of several anti-cancer drugs, as rapidly dividing cells (such as cancer cells) rely on precise control of microtubule dynamics for proper mitosis. Drugs targeting microtubule dynamics either stabilize microtubules (e.g., taxanes) and prevent depolymerization or destabilize them (e.g., vinca alkaloids, colchicine), leading to cell cycle arrest and apoptosis of proliferating cells. Targeting this process is clinically important but presents safety concerns, especially regarding neurotoxicity and resistance. This entry is not a valid molecule/receptor for structured target annotation, but describes a pharmacological strategy used in modern therapeutics.
Microtubule stabilization (prevents depolymerization; e.g., taxanes like paclitaxel) Microtubule destabilization (prevents polymerization or enhances depolymerization; e.g., vinca alkaloids, colchicine)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule dynamics disruption.